| Title: |
Trastuzumab deruxtecan versus treatment of physician’s choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study |
| Authors: |
Yamashita, ToshinariAff1; Sohn, Joo HyukAff2; Tokunaga, ErikoAff3; Niikura, NaokiAff4; Park, Yeon HeeAff5; Lee, Keun SeokAff6; Chae, Yee SooAff7; Xu, BingheAff8; Wang, XiaojiaAff9; Im, Seock-AhAff10; Li, WeiAff11; Lu, Yen-ShenAff12; Aguilar, Cecilia OrbegosoAff13; Nishijima, SoichiroAff14; Nishiyama, YujiAff14; Sugihara, MasahiroAff14; Modi, ShanuAff15; Tsurutani, JunjiAff16, Aff17, IDs12282024016007_cor18 |
| Source: |
Breast Cancer. 31(5):858-868 |
| Database: |
Springer Nature Journals |